Skip to Main Content

Paper Details

PKC modulator bryostatin-1 therapeutically targets CNS innate immunity to attenuate neuroinflammation and promote remyelination.
bioRxiv
1
2023
Author NameAffiliation
Peter A CalabresiJohns Hopkins University School of Medicine Baltimore
Peter A CalabresiJohns Hopkins University School of Medicine Baltimore
  • 1 - 2

Datasets

Release 1.2